首页 | 本学科首页   官方微博 | 高级检索  
     


Implementing a breast cancer registry and treatment plan/summary program in clinical practice: A pilot program
Authors:Ann H. Partridge MD  MPH  Virginia W. Norris MCG  Victoria S. Blinder MD  Bruce A. Cutter MD  MMM  Michael T. Halpern MD  Jennifer Malin MD  Michael N. Neuss MD  Antonio C. Wolff MD
Affiliation:1. Dana‐Farber Cancer Institute and Brigham and Women's Hospital, Boston, MassachusettsFax: (617) 632‐1930;2. American Society of Clinical Oncology, Alexandria, Virginia;3. Memorial Sloan Kettering Cancer Center, New York, New York;4. Group Health Cooperative, Spokane, Washington;5. RTI International, Washington, DC;6. VA Greater Los Angeles Healthcare System and Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California;7. Vanderbilt‐Ingram Cancer Center, Nashville, Tennessee;8. Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland
Abstract:

BACKGROUND:

There is a need to better measure and improve the quality of oncology care and improve communication with patients and other providers. The American Society of Clinical Oncology Breast Cancer Registry (BCR) pilot evaluated the feasibility and acceptability of prospective data collection for quality assessment in daily clinical practice. Data were used to create and share treatment plans/summaries (TPSs) at the point of care.

METHODS:

Using a web‐based tool, 20 diverse practices entered clinical data on each new early‐stage breast cancer patient into the BCR for 14 months (September 2009 through November 2010). The tool created individual TPSs that were shared with patients. Practices received practice‐specific and aggregate BCR quality measures data, participated in a survey, and received a participation stipend.

RESULTS:

Twenty practices entered 2014 patients into the BCR, collecting demographic, clinical, and treatment information. Fifty‐two percent of practice participants replied to an end‐of‐pilot survey: 73% were satisfied with the BCR and web‐based tool, 31% expressed concern regarding time and effort, and 52% reported additional practice costs during the pilot. Among those who created or shared the TPSs, 90% thought the documents improved oncologist‐patient communication, and 95% favored using BCR data for practice quality improvement.

CONCLUSIONS:

Prospective data collection for quality assessment is feasible and allows sharing of TPSs with patients at the point of care. Future efforts should focus on decreasing implementation burden to practices, broadening participation, examining costs, and, most importantly, assessing its effects on patient outcomes. Cancer 2013. © 2012 American Cancer Society.
Keywords:treatment plan  treatment summary  quality of care  quality assessment  breast cancer
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号